Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
BEFREE |
Multivariate cox regression analysis revealed that BTN3A2 was an independently prognostic signature of TNBC, as well as weighted correlation network analysis suggested BTN3A2 was only correlated with TNBC, rather than other subtypes of BRCA.
|
31692043 |
2020 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
Multivariate cox regression analysis revealed that BTN3A2 was an independently prognostic signature of TNBC, as well as weighted correlation network analysis suggested BTN3A2 was only correlated with TNBC, rather than other subtypes of BRCA.
|
31692043 |
2020 |
Schizophrenia
|
0.120 |
Biomarker
|
disease |
BEFREE |
We identified BTN3A2 as a potential risk gene for schizophrenia.
|
31133542 |
2019 |
Schizophrenia
|
0.120 |
Biomarker
|
disease |
BEFREE |
After comparing with the differentially expressed genes in SCZ brain tissues, 49 overlapped genes were identified for meQTLs, such as ZSCAN12, BTN3A2 and HLA-DQA1.
|
31425724 |
2020 |
Carcinoma, Ovarian Epithelial
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
|
22685580 |
2012 |
Carcinoma, Ovarian Epithelial
|
0.040 |
Biomarker
|
disease |
BEFREE |
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
|
18398031 |
2008 |
Carcinoma, Ovarian Epithelial
|
0.040 |
Biomarker
|
disease |
BEFREE |
Consequently, CD277, and likely other butyrophilins and butyrophilin-like molecules, emerge as regular players in the orchestration of immunosuppressive networks in ovarian cancer, and therefore new targets for interventions to overcome immune evasion and boost anti-tumor immunity in cancer patients.
|
21113407 |
2010 |
Carcinoma, Ovarian Epithelial
|
0.040 |
Biomarker
|
disease |
BEFREE |
However, immune infiltrations were highly correlated with BTN3A2 in triple-negative breast cancer (TNBC), compared with OV and other subtypes of BRCA.
|
31692043 |
2020 |
Epithelial ovarian cancer
|
0.020 |
Biomarker
|
disease |
BEFREE |
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
|
18398031 |
2008 |
Epithelial ovarian cancer
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
|
22685580 |
2012 |
ovarian neoplasm
|
0.020 |
Biomarker
|
disease |
BEFREE |
However, immune infiltrations were highly correlated with BTN3A2 in triple-negative breast cancer (TNBC), compared with OV and other subtypes of BRCA.
|
31692043 |
2020 |
ovarian neoplasm
|
0.020 |
Biomarker
|
disease |
BEFREE |
Consequently, CD277, and likely other butyrophilins and butyrophilin-like molecules, emerge as regular players in the orchestration of immunosuppressive networks in ovarian cancer, and therefore new targets for interventions to overcome immune evasion and boost anti-tumor immunity in cancer patients.
|
21113407 |
2010 |
Malignant neoplasm of ovary
|
0.020 |
Biomarker
|
disease |
BEFREE |
However, immune infiltrations were highly correlated with BTN3A2 in triple-negative breast cancer (TNBC), compared with OV and other subtypes of BRCA.
|
31692043 |
2020 |
Malignant neoplasm of ovary
|
0.020 |
Biomarker
|
disease |
BEFREE |
Consequently, CD277, and likely other butyrophilins and butyrophilin-like molecules, emerge as regular players in the orchestration of immunosuppressive networks in ovarian cancer, and therefore new targets for interventions to overcome immune evasion and boost anti-tumor immunity in cancer patients.
|
21113407 |
2010 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
γ9δ2T cells, which express Vγ9 and Vδ2 chains of the T cell receptor (TCR), mediate cancer immune surveillance by sensing early metabolic changes in malignant leukemic blast and not their healthy hematopoietic stem counterparts via the γ9δ2TCR targeting joined conformational and spatial changes of CD277 at the cell membrane (CD277J).
|
30871629 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
It is important to note that these associations were independent of the HLA-DRB1-DQA1-DQB1 genes, as well as of associations observed at HLA-A, -B and -C. Taken together, our results identify PRSS16 and BTN3A2, two genes thought to play important roles in regulating the immune response, as potentially novel susceptibility genes for T1D.
|
19295542 |
2009 |
Hepatitis C
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
BTN3A2 rs9104 was strongly associated with genotype 1 infection and the haplotype BTN3A3 rs13220495 CC+IL28B genotype CC was universal in patients with hepatitis C genotype 3a.
|
25928882 |
2016 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
We have associated variants at 1p35.2 and 6p22.1 with gastric cancer risk, indicating a role for SPOCD1 and BTN3A2 in gastric carcinogenesis.
|
28246015 |
2017 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
|
22685580 |
2012 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We have associated variants at 1p35.2 and 6p22.1 with gastric cancer risk, indicating a role for SPOCD1 and BTN3A2 in gastric carcinogenesis.
|
28246015 |
2017 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We have associated variants at 1p35.2 and 6p22.1 with gastric cancer risk, indicating a role for SPOCD1 and BTN3A2 in gastric carcinogenesis.
|
28246015 |
2017 |
Tumor Cell Invasion
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
BTN3A2 is overexpressed in gastric tumors, and deletion of BTN3A2 inhibited proliferation, migration, and invasion of gastric cancer cells.
|
28246015 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
γ9δ2T cells, which express Vγ9 and Vδ2 chains of the T cell receptor (TCR), mediate cancer immune surveillance by sensing early metabolic changes in malignant leukemic blast and not their healthy hematopoietic stem counterparts via the γ9δ2TCR targeting joined conformational and spatial changes of CD277 at the cell membrane (CD277J).
|
30871629 |
2019 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
0.010 |
Biomarker
|
disease |
BEFREE |
BTN3A2 was shown to be the most abundant isoform in PDAC and was stress-regulated.
|
29296524 |
2017 |
Triple Negative Breast Neoplasms
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immune cell subtypes correlation analysis showed that BTN3A2 was highly correlated with general T, CD8+ T, T helper type 1, exhausted T cells, and dendritic cells in TNBC.
|
31692043 |
2020 |